Methods of inducing an immune response against HIV-1 using recombinant envelopes with improved coverage
US10906941B2 · kind B2 · utility
0Cited by
3References
12Claims
0Family size
Inventors
Key dates
| Filing date | Apr 15, 2014 |
| Grant date | Feb 2, 2021 |
| Priority date | — |
| Expiry date | Apr 15, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2740/16134
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates, in general, to human immunodeficiency virus-1 (HIV-1) particular, to a polyvalent vaccine for HIV-1 and to methods of making and using same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.